Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E E Powell

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|July 27, 1999
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfaC J Edwards-Smith, J R Jonsson, D M Purdie, et al.
Journal of Gastroenterology and Hepatology|September 11, 1999
Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapyC M Maguire, D H Crawford, L F Hourigan, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosisL F Hourigan, G A Macdonald, D Purdie, et al.
Journal of Medical Genetics|July 5, 2005
A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis CM M Richardson, E E Powell, H D Barrie, et al.
Journal of Hepatology|April 3, 2001
Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activationA D Clouston, J R Jonsson, D M Purdie, et al.
Internal Medicine Journal|January 15, 2016
Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver diseaseN A El-Atem, K Wojcik, L Horsfall, et al.
Internal Medicine Journal|July 10, 2013
Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early interventionK J Fagan, K M Irvine, S Kumar, et al.
Public Health|February 14, 2024
A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, AustraliaS Senanayake, A Barnett, D Brain, et al.
Gut|February 13, 2004
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeI J Hickman, J R Jonsson, J B Prins, et al.
Public Health|May 25, 2024
Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity - a data linkage studyB Sarraf, R Skoien, G Hartel, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|July 27, 1999
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfaC J Edwards-Smith, J R Jonsson, D M Purdie, et al.
Journal of Gastroenterology and Hepatology|September 11, 1999
Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapyC M Maguire, D H Crawford, L F Hourigan, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosisL F Hourigan, G A Macdonald, D Purdie, et al.
Journal of Medical Genetics|July 5, 2005
A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis CM M Richardson, E E Powell, H D Barrie, et al.
Journal of Hepatology|April 3, 2001
Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activationA D Clouston, J R Jonsson, D M Purdie, et al.
Internal Medicine Journal|January 15, 2016
Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver diseaseN A El-Atem, K Wojcik, L Horsfall, et al.
Internal Medicine Journal|July 10, 2013
Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early interventionK J Fagan, K M Irvine, S Kumar, et al.
Public Health|February 14, 2024
A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, AustraliaS Senanayake, A Barnett, D Brain, et al.
Gut|February 13, 2004
Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeI J Hickman, J R Jonsson, J B Prins, et al.
Public Health|May 25, 2024
Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity - a data linkage studyB Sarraf, R Skoien, G Hartel, et al.
Pageof 5